Dhananjaya Pal, PhD

Wake Forest Institute of Regenerative Medicine
winston salem, North Carolina, United States

Presentation(s):

• P123. Patient-Derived Lung Tumor Organoids as a Platform to Assess Novel Multi-Targeted Kinase Inhibitors

  Saturday, March 7, 2026
  9:49 AM - 9:56 AM MST